Johnson & Johnson

Johnson & Johnson CEO testifies he ‘did not read all the documents’ related to potential asbestos in baby powder

Johnson & Johnson misses revenue estimates as sales of blockbuster drugs disappoint

Washington State sues Johnson & Johnson over its role in the opioid crisis

Major retailers pull some Johnson & Johnson baby powder bottles from shelves

Johnson & Johnson recalls 33,000 bottles of baby powder as FDA finds asbestos in sample

Johnson & Johnson shares hit after jury awards $8-billion in damages in drug case

Jury awards man $8-billion because Johnson & Johnson failed to warn Risperdal users of male breast growth

Johnson & Johnson settles with two Ohio counties over opioid crisis lawsuit

Five drugmakers look to use Purdue Pharma’s bankruptcy to settle opioid suits: report

Johnson & Johnson appeals Oklahoma court’s US$572-million opioid ruling

Will large drug company payouts improve the safety of prescription drug users now, or in the future?

J&J lawyer says Oklahoma opioid judgment has no binding impact in B.C. case

More provinces join in class-action suit against opioid makers

Oklahoma judge finds Johnson & Johnson helped fuel state’s opioid epidemic, orders $572-million payment

Shareholder value is no longer everything, top CEOs say

Deployment of second Ebola vaccine would not be quick fix, experts warn

Johnson & Johnson beats profit estimates on strong demand for cancer drugs

Johnson & Johnson faces U.S. criminal probe related to baby powder: report

Drug maker’s greed helped fuel opioid crisis, Oklahoma claims at trial

Johnson & Johnson raises sales forecast, driven by strength in pharmaceuticals